Experts debunk benefits of common cough syrups

Image
Press Trust of India London
Last Updated : Jan 25 2013 | 5:33 AM IST

For instance, one manufacturer claimed that their preparation "works deep down to loosen phlegm, clear bronchial congestion, and make your cough more productive."

Experts say the product's key active ingredient is guaifenesin, but the experts said the studies which are used to support the claims of its effectiveness are low quality. Nor has the company provided any evidence of effectiveness.

The active ingredients of another mixture are sugar alcohol (glycerol) and liquid sugar (sucrose), the 'Daily Mail' reported.

It also includes other sugars such as black treacle. The experts said the mixture is roughly half sugar and its effectiveness is "unproven".

The experts also found out that one week of the adult maximum dose of the Benylin Tickly Coughs mixture is equivalent to eating the sugar contained in five Mars bars.

The team was similarly sceptical about the claims made for Covonia Herbal Mucus Cough Syrup.

UK consumer campaigners Which? said companies must be honest about what these products, which are often expensive, can do, particularly when it comes to important issues like health.

"We spend billions on over-the-counter pharmacy products each year but we've found evidence of popular products making claims that our experts judged just aren't backed by sufficient evidence," a spokesman said.

Companies should be upfront with the evidence behind the claims they make so that consumers can make an informed decision," the spokesman said.

A number of studies have identified glucosamine, omega 3 and chondroitin as having beneficial effects in terms of protecting ageing joints. And various medicines have latched on to these claims in order to increase sales.

However, the European Food Safety Authority (EFSA) recently ruled the evidence was not strong enough to substantiate the claims.

The manufacturers of the products examined by Which? said that they all met the standards of the independent Medicines and Health-care products Regulatory Agency (MHRA), which requires evidence to demonstrate they work.

  

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 15 2012 | 4:45 PM IST

Next Story